---
title: "Vesting Schedule, Definition | MedTech Terms"
description: "Timeline over which equity is earned by an employee or founder. Plain-English Investment &amp; Finance definition for MedTech teams, with examples and related terms"
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/vesting#term",
        "name": "Vesting Schedule",
        "description": "Vesting is the process by which equity (founder shares, options, RSUs) becomes non-forfeitable over time. The standard schedule is 4 years with a 1-year cliff: 25% vests at the 1-year anniversary, then monthly thereafter.",
        "url": "https://medtechterms.com/terms/vesting",
        "termCode": "vesting",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/vesting#article",
        "headline": "Vesting Schedule",
        "description": "Timeline over which equity is earned by an employee or founder.",
        "url": "https://medtechterms.com/terms/vesting",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/vesting"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/vesting#term"
        },
        "articleSection": "Investment & Finance",
        "inLanguage": "en",
        "keywords": "Vesting Schedule, Investment & Finance, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "Carta: vesting",
            "url": "https://carta.com/learn/equity/stock-options/vesting/",
            "publisher": {
              "@type": "Organization",
              "name": "Carta"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "PitchBook - MedTech Coverage",
            "url": "https://pitchbook.com/news/articles/topic/healthtech",
            "publisher": {
              "@type": "Organization",
              "name": "PitchBook"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "NVCA Model Documents",
            "url": "https://nvca.org/model-legal-documents/",
            "publisher": {
              "@type": "Organization",
              "name": "NVCA"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/option-pool#term",
            "name": "Employee Option Pool",
            "url": "https://medtechterms.com/terms/option-pool"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/cap-table#term",
            "name": "Capitalization Table",
            "alternateName": "Cap Table",
            "url": "https://medtechterms.com/terms/cap-table"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Investment & Finance",
            "item": "https://medtechterms.com/terms?cat=Investment%20%26%20Finance"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Vesting Schedule",
            "item": "https://medtechterms.com/terms/vesting"
          }
        ]
      },
      {
        "@type": "FAQPage",
        "@id": "https://medtechterms.com/terms/vesting#faq",
        "mainEntity": [
          {
            "@type": "Question",
            "name": "How does vesting impact the MedTech regulatory landscape?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Vesting primarily impacts the MedTech regulatory landscape indirectly by ensuring business stability and continuity of leadership. This stability is crucial for maintaining a robust quality management system and consistently addressing regulatory obligations, as stipulated by regulations like 21 CFR 820 and standards such as ISO 13485."
            }
          },
          {
            "@type": "Question",
            "name": "Are there specific MedTech regulations regarding vesting?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "No, there are no direct MedTech-specific regulations that mandate or describe vesting schedules. Vesting is primarily a corporate governance and human resources mechanism, governed by contract law and tax regulations, not medical device regulations."
            }
          },
          {
            "@type": "Question",
            "name": "Why would investors care about a MedTech company's vesting schedule?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Investors care about a MedTech company's vesting schedule because it demonstrates founder and key employee commitment and alignment of interests. This commitment is vital for the long-term success of the company, especially given the lengthy development and regulatory approval timelines in the MedTech industry."
            }
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Investment & Finance](/terms?cat=Investment%20%26%20Finance)
6.  /
7.  Vesting Schedule

[All terms](/terms)

Investment & Finance [Startup Lifecycle](/ecosystems/startup-lifecycle)

# Vesting Schedule

Timeline over which equity is earned by an employee or founder.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

Vesting is the process by which equity (founder shares, options, RSUs) becomes non-forfeitable over time. The standard schedule is 4 years with a 1-year cliff: 25% vests at the 1-year anniversary, then monthly thereafter. 

What the regulation says

While not a direct regulatory requirement for MedTech product approval, vesting schedules, particularly for founders and key personnel, are critical for business stability and demonstrating long-term commitment. This stability indirectly supports compliance with quality management system requirements, such as those in 21 CFR Part 820 ( [Quality System Regulation](/terms/qsr)) and  [ISO 13485](/terms/iso-13485):2016, by ensuring consistent leadership and resource allocation for regulatory affairs and product development. Investors and regulatory bodies assess the overall viability and management structure of a MedTech company, where founder vesting can be a positive indicator of robust governance. 

## What this means in practice

Founder vesting reassures investors that co-founders are committed; without it, a founder who leaves in year one keeps a huge chunk of the company. 

## Examples

-   A MedTech startup implements a 4-year founder vesting schedule with a 1-year cliff to assure Series A investors of the co-founders' long-term dedication to achieving FDA clearance for their novel diagnostic device.
-   An early-stage MedTech company grants stock options to its lead regulatory affairs specialist with a 3-year vesting period to incentivize their continued employment through the complex EU MDR CE marking process.
-   During due diligence for acquisition, a large MedTech firm reviews the vesting schedules of the target company's executive team to ensure key talent will remain post-acquisition, critical for the ongoing compliance of their acquired product portfolio.

Common pitfalls

-   • Assuming vesting schedules are only for founders, neglecting the importance of vesting for other key employees involved in critical regulatory or quality functions. 
-   • Failing to clearly document vesting agreements, potentially leading to disputes that disrupt business operations and regulatory compliance efforts. 
-   • Not considering the impact of accelerated vesting clauses during mergers or acquisitions on intellectual property ownership or continuity of key personnel. 
-   • Overlooking tax implications of different vesting structures for employees, which can affect retention and morale. 
-   • Drafting overly complex vesting conditions that are difficult to administer or understand by the vested parties. 

## Frequently asked questions

How does vesting impact the MedTech regulatory landscape? 

Vesting primarily impacts the MedTech regulatory landscape indirectly by ensuring business stability and continuity of leadership. This stability is crucial for maintaining a robust quality management system and consistently addressing regulatory obligations, as stipulated by regulations like 21 CFR 820 and standards such as  [ISO 13485](/terms/iso-13485). 

Are there specific MedTech regulations regarding vesting? 

Why would investors care about a MedTech company's vesting schedule? 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Investment & Finance

Capitalization Table(Cap Table) 

Ledger of all securities issued by a company and who owns them.





](/terms/cap-table)[

Investment & Finance

Employee Option Pool

Shares reserved for issuance to employees as stock options.





](/terms/option-pool)

### More in Investment & Finance

· Same category 

[

Investment & Finance

409A Valuation

An independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options.





](/terms/409a-valuation)[

Investment & Finance

Anti-Dilution Protection

Adjustment that protects investors if the company raises a future round at a lower price.





](/terms/anti-dilution)[

Investment & Finance

Bridge Round

Interim financing between priced rounds, usually convertible.





](/terms/bridge-round)[

Investment & Finance

Burn Rate

Rate at which a company spends cash, typically expressed monthly.





](/terms/burn-rate)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (1)

-   [Startup Lifecycle](/ecosystems/startup-lifecycle)

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

Carta· 1 PitchBook· 1 NVCA· 1 

1.  [1 
    
    Carta: vesting
    
    Verified 
    
    Carta · carta.com 
    
    
    
    ](https://carta.com/learn/equity/stock-options/vesting/)
2.  [2 
    
    PitchBook - MedTech Coverage
    
    Verified 
    
    PitchBook · pitchbook.com 
    
    
    
    ](https://pitchbook.com/news/articles/topic/healthtech)
3.  [3 
    
    NVCA Model Documents
    
    Verified 
    
    NVCA · nvca.org 
    
    
    
    ](https://nvca.org/model-legal-documents/)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Diligencing a MedTech cybersecurity posture?

Blue Goat Cyber supports investors and acquirers with cybersecurity diligence on connected MedTech assets.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Investment & Finance

Sources

3

Updated

5/5/2026

[Compare with another term](/compare?a=vesting)

Learn in 60 seconds

Card Lesson Quiz

Timeline over which equity is earned by an employee or founder.

-   · Founder vesting reassures investors that co-founders are committed; without it, a founder who leaves in year one keeps a huge chunk of the company. 
-   · The standard schedule is 4 years with a 1-year cliff: 25% vests at the 1-year anniversary, then monthly thereafter. 

Remember this

Watch out: Assuming vesting schedules are only for founders, neglecting the importance of vesting for other key employees involved in critical regulatory or quality functions.

Related terms

-   [Employee Option Pool ](/terms/option-pool)
-   [Capitalization Table(Cap Table) ](/terms/cap-table)

You may also need

Auto-suggested from Investment & Finance and shared keywords.

-   [Liquidity Event ](/terms/liquidity-event)
-   [409A Valuation ](/terms/409a-valuation)
-   [Drag-Along and Tag-Along Rights ](/terms/drag-tag-along)
-   [Initial Public Offering(IPO) ](/terms/ipo)
-   [Pre-Money Valuation ](/terms/pre-money-valuation)
-   [Preferred Stock ](/terms/preferred-stock)

[All Investment & Finance terms](/terms?cat=Investment%20%26%20Finance)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)